Novartis pumping $1B into China R&D

Novartis plans to pump a billion dollars into its R&D operations in China over the next five years, expanding its scientific ranks in the Asian economic powerhouse from 160 to 1,000 as the pharma giant constructs a new research complex designed to rival centers in Europe and the U.S. Report